Torray Investment Partners LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 98758 Bethesda, MD

Position in AXSM

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$3,653,926

+$1,156,825 QoQ

Shares Held

14,928

+1.0% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#188

of 503 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

Torray Investment Partners LLC holds $61,710,475 across 8 Biotechnology names. AXSM ranks #5 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	602,028	$33,755,709
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,215	$7,557,746
3	KRYS	Krystal Biotech, Inc.	12,156	$4,518,020
4	BMRN	Biomarin Pharmaceutical Inc	77,705	$4,446,280
5	AXSM	Axsome Therapeutics, Inc. This page	14,928	$3,653,926
6	HALO	Halozyme Therapeutics, Inc.	38,703	$3,029,283
7	SNDX	Syndax Pharmaceuticals Inc	133,835	$2,925,633
8	VSTM	Verastem, Inc.	477,455	$1,823,878

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,653,926	14,928	+1.0%	Shares	Sole	2026-07-30
2026-03-31	$2,497,101	14,774	-0.1%	Shares	Sole	2026-05-01
2025-12-31	$2,701,976	14,794	-15.1%	Shares	Sole	2026-01-28
2025-09-30	$2,115,537	17,419	+2.1%	Shares	Sole	2025-10-22
2025-06-30	$1,781,415	17,065	-0.3%	Shares	Sole	2025-08-05
2025-03-31	$1,996,239	17,116	-0.3%	Shares	Sole	2025-05-08
2024-12-31	$1,453,092	17,174	+45.3%	Shares	Sole	2025-02-06
2024-09-30	$1,062,533	11,823	+0.6%	Shares	Sole	2024-11-05
2024-06-30	$945,633	11,747	+11.5%	Shares	Sole	2024-08-06
2024-03-31	$840,932	10,538	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.